WSJ: DOJ nearing approval of CVS-Aetna, Cigna-Express Scripts mergers

The DOJ could approve both mergers within the next few weeks, according to a WSJ report. (skpy/Flickr)

Antitrust regulators at the Department of Justice are closing in on approving two massive vertical healthcare mergers in CVS-Aetna and Cigna-Express Scripts.

Both deals could get federal approval within the next few weeks, sources told The Wall Street Journal on Wednesday.

For CVS-Aetna, part of that approval could hinge on the companies selling off some of their assets, particularly in the Part D market where consumer advocacy groups have repeatedly raised concerns about consolidation within Medicare's drug benefit program. A Kaiser Family Foundation analysis earlier this year found that the two merged companies, plus UnitedHealth Group, would cover 71% of Part D plans.

Innovation Awards

Submit your nominations for the FierceHealthcare Innovation Awards

The FierceHealthcare Innovation Awards showcases outstanding innovation that is driving improvements and transforming the industry. Our expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. Deadline for submissions is this Friday, October 18th.

Suggested Articles

As drugmakers face billions in legal settlements and judgments, we must keep our eye on what will truly defeat the opioid crisis.

As the public debate on health reform rolls on, a new report analyzes how these different approaches could impact insurers' bottom lines.

A House panel is going to consider several changes to Nancy Pelosi's drug prices plan, including stiff penalties for not being transparent.